1. Home
  2. TRNS vs MRVI Comparison

TRNS vs MRVI Comparison

Compare TRNS & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcat Inc.

TRNS

Transcat Inc.

HOLD

Current Price

$88.86

Market Cap

861.5M

Sector

Industrials

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$5.99

Market Cap

890.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNS
MRVI
Founded
1964
2014
Country
United States
United States
Employees
N/A
416
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
861.5M
890.9M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
TRNS
MRVI
Price
$88.86
$5.99
Analyst Decision
Strong Buy
Buy
Analyst Count
1
4
Target Price
$116.00
$4.13
AVG Volume (30 Days)
178.4K
3.1M
Earning Date
05-18-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
0.57
N/A
Revenue
$331,877,000.00
$185,743,000.00
Revenue This Year
$21.75
$12.54
Revenue Next Year
$7.55
$7.87
P/E Ratio
$156.19
N/A
Revenue Growth
19.20
N/A
52 Week Low
$50.23
$1.99
52 Week High
$94.76
$6.55

Technical Indicators

Market Signals
Indicator
TRNS
MRVI
Relative Strength Index (RSI) 51.54 69.95
Support Level $86.10 $3.27
Resistance Level $94.48 N/A
Average True Range (ATR) 3.75 0.32
MACD -0.58 0.05
Stochastic Oscillator 28.98 69.98

Price Performance

Historical Comparison
TRNS
MRVI

About TRNS Transcat Inc.

Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

Share on Social Networks: